---
schema_version: "secwatch.filing_event.v1"
accession: "0001919246-26-000125"
form_type: "8-K"
ticker: "PTHS"
cik: "0001919246"
company_name: "Pelthos Therapeutics Inc."
filed_at: "2026-10-01T21:15:10+00:00"
generated_at: "2026-10-12T14:28:07.073956+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Pelthos holders re-elect 8 directors, approve 2026 equity plan with 500,000-share reserve

## Summary
- Eight director nominees elected at the Sept 29, 2026 annual meeting; Matthew Pauls received the most withheld votes: 110,700 vs 2,775,221 for.
- Grant Thornton LLP ratified as independent auditor for fiscal 2026: 3,394,740 votes for, 1 against and 1,353 abstaining.
- 2026 Equity Incentive Plan approved with 2,698,543 votes for, 187,365 against and 13 abstaining; it replaces the 2023 plan and reserves 500,000 shares plus a 5% annual evergreen increase.
- Record date Aug 4, 2026: 3,828,469 common shares and 52,128 Series A preferred outstanding; 3,396,094 votes present (70.0%) constituted a quorum.
- Non-employee director compensation capped at $750,000 per fiscal year ($1,000,000 in initial service year); forfeited shares can be reissued under the plan.

## SEC filing metadata
- accession: 0001919246-26-000125
- form_type: 8-K
- ticker: PTHS
- cik: 0001919246
- company_name: Pelthos Therapeutics Inc.
- filed_at: 2026-10-01T21:15:10+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1919246/000191924626000125/0001919246-26-000125-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1919246/000191924626000125/pths-20260929.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001919246-26-000125
- JSON: https://secwatch.observer/filing/0001919246-26-000125.json
- Plain text: https://secwatch.observer/filing/0001919246-26-000125.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.